Thus, CD8 T cells activate the NLRP3 in antigen-presenting cells (APCs) that promote IL1β maturation and contribute to the induction of antigen-specific anti-tumor immunity amplifying the CD8 effector functions [144]. This evidence concerns the gene NLRP3 and neoplasm.